Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...

SPDR S&P Biotech ETF Trading Up 1.3 % Shares of NYSEARCA XBI opened at $87.13 on Monday. The firm has a market cap of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF ...

In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Alnylam Pharmaceuticals ...

The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index. The Fund uses a passive management ...

Assess our live XBI chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style, bar chart or Heiken Ashi. There are dozens of tools ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

There are other ETFs in the space which investors could consider as well. SPDR S&P Biotech ETF (XBI) tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

EMHY iShares J.P. Morgan EM High Yield Bond ETF ...